Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001628280-25-010688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Patel Chintu | Co-CEO, Dir | F - Tax | $8.77 | -320.8K | 818.0K | -28% | -$2.81M |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Patel Chintu | Co-CEO, Dir | M - OptEx | — | +672.3K | 910.6K | +282% | — |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Patel Chintu | Co-CEO, Dir | M - OptEx | $0.00 | -672.3K | 277.8K | -71% | $0 |
| DM | 2025-03-05 | 2025-03-03 | AMRX | Patel Chintu | Co-CEO, Dir | A - Grant | $0.00 | +1.13M | 239.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-04 | F | D | 46,528 | $8.84 | 864,033 | D | — | — | (F5) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. |
| 2 | Common | Class A Common Stock | 2025-03-03 | F | D | 274,307 | $8.76 | 817,969 | D | — | — | (F2) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units. |
| 3 | Common | Class A Common Stock | 2025-03-03 | M | A | 579,710 | — | 1,092,276 | D | — | — | (F1) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one -for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 2. |
| 4 | Common | Class A Common Stock | 2025-03-04 | M | A | 92,592 | — | 910,561 | D | — | — | (F3) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issues was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5 (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 5 | Derivative | Performance-Based Restricted Stock Units | 2025-03-03 | M | D | 579,710 | $0.00 | 0 | D | — · — to — | 579,710 Class A Common Stock | (F1) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one -for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 2. |
| 6 | Derivative | Performance-Based Restricted Stock Units | 2025-03-03 | A | A | 890,410 | $0.00 | 890,410 | D | — · — to — | 890,410 Class A Common Stock | (F6) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F7) Represents a performance-based restricted stock unit grant of 445,205 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period. |
| 7 | Derivative | Restricted Stock Units | 2025-03-03 | A | A | 239,726 | $0.00 | 239,726 | D | — · — to — | 239,726 Class A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F8) The restricted stock units vest in four equal annual installments beginning on March 3, 2026. |
| 8 | Derivative | Restricted Stock Units | 2025-03-04 | M | D | 92,592 | $0.00 | 277,778 | D | — · — to — | 92,592 Class A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F9) On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. |